View
7
Download
0
Category
Preview:
Citation preview
Maine DHHS
COVID-19 Vaccines Information for Clinicians
Stephen Sears, ME CDCLisa M. Letourneau MD, MPH, ME DHHS
December 21, 2020(Core Set)
Welcome
2
• Introductions• Session goals & format• CME available (0.5 AMA PRA Cat 1 Credit/session)If CME desired, pls enter your name & email in chat!(Note: if phone only, email your name & date of sessions attended to Sabrina.L.Beane@maine.gov)
• Future sessions• Current context
mailto:sabrina.L.beane@maine.gov
The planners and faculty for this activity do not have any relevant financial relationships to
disclose with any Commercial Interests and do not have any conflicts of interest to resolve
3
Disclosures
COVID-19 Vaccines – How We Save Lives
4
Vaccines don’t save lives. Vaccinations save lives.
COVID-19 Vaccines – Info for Clinicians
5
• Context• Science of vaccines• Vaccine development & approval process• Initial vaccines• Vaccine distribution planning• Vaccine hesitancy & patient conversations• Vaccine storage, handling & administration• Reporting & tracking adverse events
6
Nucleic Acid Vaccines
US CDC: What Clinicians Need to Know About Pfizer-BioNTech COVID-19 Vaccine
https://www.cdc.gov/vaccines/covid-19/downloads/pfizer-biontech-vaccine-what-Clinicians-need-to-know.pdf
7
mRNA Vaccines: Pfizer & Moderna
US CDC: What Clinicians Need to Know About Pfizer-BioNTech COVID-19 Vaccine
https://www.cdc.gov/vaccines/covid-19/downloads/pfizer-biontech-vaccine-what-Clinicians-need-to-know.pdf
8
Pfizer-BioNTech COVID-19 Vaccine
US CDC: What Clinicians Need to Know About Pfizer-BioNTech COVID-19 Vaccine
https://www.cdc.gov/vaccines/covid-19/downloads/pfizer-biontech-vaccine-what-Clinicians-need-to-know.pdf
9
Pfizer Clinical Trial: Safety
US CDC: What Every Clinician Should Know COVID-19 Vaccine Safety
https://emergency.cdc.gov/coca/calls/2020/callinfo_121420.asp
Pfizer BioNTech• mRNA vaccine• Trial with >44,000• Efficacy 94.5%• Minimal adverse rxn’s• 2nd dose at 21D• Auth’d for ≥16yo• Storage at -70C• Can be refridg’d for 5D
Moderna• mRNA vaccine• Trial with >30,000• Efficacy >94.1%• Minimal adverse rxn’s• 2nd dose at 28D• Auth’d for ≥18yo• Storage at -20C• Can be refridg’d for 30D
10
Key Similarities & Differences
11
Ingredients of Pfizer & Moderna Vaccines
12
Pfizer Clinical Trial: Safety
US CDC: What Clinicians Need to Know About Pfizer-BioNTech COVID-19 Vaccine
https://www.cdc.gov/vaccines/covid-19/downloads/pfizer-biontech-vaccine-what-Clinicians-need-to-know.pdf
13
Post-Vaccine Sx & Reactogenicity
14
US CDC: Prepare to Manage Anaphylaxis
US CDC: What Clinicians Need to Know Pfizer & Moderna Vaccines
https://emergency.cdc.gov/coca/ppt/2020/12.18.2020_COCA_Pfizer-BioNTech-and-Moderna_COMBINED-2.pdf
15
US CDC: Prepare to Manage Anaphylaxis
US CDC: What Clinicians Need to Know Pfizer & Moderna Vaccines
https://emergency.cdc.gov/coca/ppt/2020/12.18.2020_COCA_Pfizer-BioNTech-and-Moderna_COMBINED-2.pdf
Proposed Phases of COVID-19 Vaccination16-64 years with high -riskmedical conditions (>110M)
16-64 years Without high -risk
medical conditions(
17
Additional Consideration for Phase 1a • Limited initial supply means sub-prioritization needed• First supplies prioritized within Phase 1a to staff teams
in highest-risk units – i.e.– ICUs/ Critical Care Units– EDs– COVID units
• ME DHHS/CDC working to identify next 1a priority grps• Vaccinating clinical staff needs to anticipate /
accommodate likely vaccine reaction sx (may need to vaccinate in staff ‘waves’)
• Ongoing safety monitoring is critical
• Hospitals• Pharmacies
– Pharmacy Partnership for LTC (Walgreens, CVS)– Commercial pharmacies
• EMS• Enrolled/registered physician & dental
practices• Public health nursing
18
COVID-19 – Maine Vaccinators
Additional COVID Vaccine Resources
19
• HHS Fact Sheet Operation Warp Speed• NY Times Vaccine Tracker• ME COVID Vaccine Plan• ME CDC COVID-19 Vaccine Provider Portal• ME CDC COVID-19 Vaccine Info for Clinicians• ME CDC COVID-19 Vaccine Provider Enrollment• US CDC COVID-19 Vaccine Resources for Providers• US CDC COVID-19 Vaccine Training for Providers• US CDC Engaging Patients in COVID Vaccines• US CDC Answering Likely Questions on COVID Vaccine• FDA Issues EUA for Pfizer-BioNTech COVID-19 Vaccine
https://www.hhs.gov/coronavirus/explaining-operation-warp-speed/index.htmlhttps://www.maine.gov/dhhs/mecdc/infectious-disease/immunization/covid-19-providers/index.shtmlhttps://www.maine.gov/dhhs/mecdc/infectious-disease/immunization/covid-19-providers/index.shtmlhttps://www.maine.gov/dhhs/mecdc/infectious-disease/immunization/covid-19-providers/enrollment.shtmlhttps://www.cdc.gov/coronavirus/2019-ncov/hcp/vaccination.htmlhttps://www2.cdc.gov/vaccines/ed/covid19/SHVA/index.asphttps://www.cdc.gov/vaccines/covid-19/hcp/engaging-patients.htmlhttps://www.cdc.gov/vaccines/covid-19/hcp/answering-questions.htmlhttps://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19
20
ME CDC COVID-19 Vaccine Resources
ME CDC COVID Vaccine Resources
Vaccine questions? Email: C19vaccine.MECDC@maine.gov
https://www.maine.gov/dhhs/mecdc/infectious-disease/immunization/covid-19-providers/index.shtmlmailto:C19vaccine.MECDC@maine.gov
• Stephen Sears MD, MPHConsulting Epidemiologist, Maine CDCStephen.sears@maine.govC: 207-458-2351
• Lisa Letourneau MD, MPHSenior Advisor, Healthcare Delivery System Change, ME DHHSLisa.Letourneau@maine.govC: 207-415-4043
21Maine Department of Health and Human Services
Presenters
mailto:Stephen.sears@maine.govmailto:Lisa.Letourneau@maine.gov
22
COVID-19 Vaccines
Questions??
Maine DHHSWelcomeDisclosuresCOVID-19 Vaccines – How We Save LivesCOVID-19 Vaccines – Info for CliniciansNucleic Acid VaccinesmRNA Vaccines: Pfizer & ModernaPfizer-BioNTech COVID-19 VaccinePfizer Clinical Trial: SafetyKey Similarities & Differences Pfizer Clinical Trial: SafetyPost-Vaccine Sx & Reactogenicity Slide Number 14Slide Number 15Proposed Phases of COVID-19 VaccinationAdditional Consideration for Phase 1a COVID-19 – Maine VaccinatorsSlide Number 19Slide Number 20Slide Number 21Slide Number 22
Recommended